Results 1 - 10 of 11 for alirocumab
  1. Alirocumab injection is used along with diet, alone or in combination with other cholesterol-lowering medications (HMG- ... lipoprotein (LDL) cholesterol ('bad cholesterol') in the blood. Alirocumab injection is also used in adults with cardiovascular ...
  2. ... of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody. Circ Cardiovasc Genet. 2015 ...
  3. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury From the National Institutes of Health (National Library of Medicine) (National Institute of Diabetes and Digestive and Kidney Diseases)  
    LiverTox® provides up-to-date, unbiased and easily accessed information on the diagnosis, cause, frequency, clinical patterns and management of liver ...
  4. ... addition to statins: Ezetimibe PCSK9 inhibitors, such as alirocumab and evolocumab (Repatha)
  5. Coronary Heart Disease From the National Institutes of Health (National Heart, Lung, and Blood Institute)  
    Coronary heart disease is a type of heart disease that happens when the arteries of the heart cannot deliver enough oxygen-rich blood to the heart. Learn ...
  6. ... fenofibrate). Nicotinic acid. Statins. PCSK9 inhibitors, such as alirocumab (Praluent) and evolocumab (Repatha). These represent a newer ...
  7. LactMed: Drugs and Lactation Database From the National Institutes of Health (National Library of Medicine)  
    Breastfeeding/Statistics and Research ... Breastfeeding ... National Library of Medicine ... The LactMed® database contains information on drugs and other chemicals ...
  8. ... or fenofibrate). Nicotinic acid . PCSK9 inhibitors, such as alirocumab (Praluent) and evolocumab (Repatha). These represent a newer ...
  9. Cholesterol Medications: Consider the Options (Mayo Foundation for Medical Education and Research)  
    Cholesterol Medicines/Start Here ... Cholesterol Medicines ... Mayo Foundation for Medical Education and Research
  10. ... and fenofibrate). Nicotinic acid . PCSK9 inhibitors, such as alirocumab (Praluent) and evolocumab (Repatha) These represent a newer ...
previous · 1 · 2 · next